Company / SG&A Expense
Avantor SG&A Expense History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$1.6B
FY2025
5-year range
$1.4B / $1.6B
FY2021-FY2025
Trend
-2.8%
vs FY2024
Sector context
#35 of 158
Health Care
What the data says
Avantor's sg&a expense of $1.6B is higher than 78% of companies in the Health Care sector (FY2025). SG&A Expense has fluctuated over the past 9 years, ranging from $450M in FY2019 to $1.6B in FY2024.
Based on SEC 10-K filings.
$1.6B in FY2025 with a 5-year CAGR of +3.0%. Top quartile in the Health Care sector.
Increased from $1.5B to $1.6B over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +5.1%
- 5-Year CAGR
- +3.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 22% in Health CareTop 78% of 158This company $1.6B Sector average $175.9B
▼
-99.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +3.0%, indicating consistent growth.
- In FY2025, sg&a expense decreased 2.8% year-over-year.
- Ranks #35 out of 158 companies in the Health Care sector.
- Peak sg&a expense was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.6B | -2.8% |
| FY2024 | $1.6B | +8.9% |
| FY2023 | $1.5B | +9.7% |
| FY2022 | $1.4B | -10.2% |
| FY2021 | $1.5B | +11.4% |
| FY2020 | $1.4B | +205.5% |
| FY2019 | $449.7M | -68.0% |
| FY2018 | $1.4B | +212.5% |
| FY2017 | $449.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026